HBM Healthcare Investments
HBM Healthcare Investments is a principal investment firm established in 2001 and based in Zug, Switzerland, with a focus on the biotechnology, human medicine, diagnostics, and medical technology sectors. The firm invests globally in approximately 40 mature emerging companies, primarily targeting private firms that demonstrate significant value creation potential. Approximately two-thirds of its portfolio consists of investments in unquoted companies, while the remainder includes public companies and funds. HBM Healthcare Investments has developed a distinctive market position through its strategic investments in firms whose products are either at advanced stages of development or already available in the market. This diversified approach allows the firm to leverage opportunities across Europe, Asia, and North America, contributing to its broad shareholder base and enhancing its investment capabilities.
Swixx Biopharma is a company that represents biopharma organizations in Central and Eastern Europe (CEE). Founded in 2014 and registered in Baar, Switzerland, it aims to take over the roles of subsidiaries or business units for multinational biopharma, over-the-counter (OTC), and medical device companies in regions they choose not to enter or have exited. Swixx operates with fully owned affiliates across multiple countries, including Albania, Bulgaria, Hungary, Poland, and Romania, among others. The company specializes in research-driven pharmaceutical and healthcare services, focusing on areas such as rare diseases, oncology-hematology, specialty medications, and self-medication. By leveraging its expertise, Swixx Biopharma provides comprehensive health treatment solutions tailored to the needs of the CEE market.
Swixx Biopharma is a company that represents biopharma organizations in Central and Eastern Europe (CEE). Founded in 2014 and registered in Baar, Switzerland, it aims to take over the roles of subsidiaries or business units for multinational biopharma, over-the-counter (OTC), and medical device companies in regions they choose not to enter or have exited. Swixx operates with fully owned affiliates across multiple countries, including Albania, Bulgaria, Hungary, Poland, and Romania, among others. The company specializes in research-driven pharmaceutical and healthcare services, focusing on areas such as rare diseases, oncology-hematology, specialty medications, and self-medication. By leveraging its expertise, Swixx Biopharma provides comprehensive health treatment solutions tailored to the needs of the CEE market.
Swixx Biopharma is a company that represents biopharma organizations in Central and Eastern Europe (CEE). Founded in 2014 and registered in Baar, Switzerland, it aims to take over the roles of subsidiaries or business units for multinational biopharma, over-the-counter (OTC), and medical device companies in regions they choose not to enter or have exited. Swixx operates with fully owned affiliates across multiple countries, including Albania, Bulgaria, Hungary, Poland, and Romania, among others. The company specializes in research-driven pharmaceutical and healthcare services, focusing on areas such as rare diseases, oncology-hematology, specialty medications, and self-medication. By leveraging its expertise, Swixx Biopharma provides comprehensive health treatment solutions tailored to the needs of the CEE market.
Swixx Biopharma is a company that represents biopharma organizations in Central and Eastern Europe (CEE). Founded in 2014 and registered in Baar, Switzerland, it aims to take over the roles of subsidiaries or business units for multinational biopharma, over-the-counter (OTC), and medical device companies in regions they choose not to enter or have exited. Swixx operates with fully owned affiliates across multiple countries, including Albania, Bulgaria, Hungary, Poland, and Romania, among others. The company specializes in research-driven pharmaceutical and healthcare services, focusing on areas such as rare diseases, oncology-hematology, specialty medications, and self-medication. By leveraging its expertise, Swixx Biopharma provides comprehensive health treatment solutions tailored to the needs of the CEE market.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.